Lv4
568 积分 2024-06-13 加入
Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancer
1个月前
已完结
A guide to antigen processing and presentation
8个月前
已完结
The role of RNA binding proteins in hepatocellular carcinoma
8个月前
已完结
The Challenges of HLA Class I Loss in Cancer Immunotherapy: Facts and Hopes
10个月前
已完结
Galectin-4 drives anti-PD-L1/BVZ resistance by regulating metabolic adaptation and tumour-associated neutrophils in hepatocellular carcinoma
10个月前
已完结
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
10个月前
已完结
Comparative effectiveness of immunotherapy versus lenvatinib in advanced hepatocellular carcinoma: A real-world analysis using target trial emulation
10个月前
已完结
HP1 and the dynamics of heterochromatin maintenance
1年前
已完结
皖公网安备34019202002308
